Loading data
ARCBNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 4.01 bn USD | 4.18 bn USD | 4.43 bn USD | 5.03 bn USD | 3.77 bn USD |
| Research and development expense | 29.1 m USD | 34.1 m USD | 52.4 m USD | 40.8 m USD | 32.8 m USD |
| Operating profit | 90.31 m USD | 244.43 m USD | 172.62 m USD | 394.53 m USD | 276.98 m USD |
| Profit before tax | 83.1 m USD | 218.71 m USD | 186.92 m USD | 388.3 m USD | 273.09 m USD |
| Income tax expense | 23 m USD | 45.35 m USD | 44.75 m USD | 93.66 m USD | 62.63 m USD |
| Net income (reported basis) | 60.1 m USD | 173.96 m USD | 195.43 m USD | 298.21 m USD | 213.52 m USD |
| Net income attributable to common shareholders | 60.1 m USD | 173.96 m USD | 195.43 m USD | 298.21 m USD | 213.52 m USD |
| Basic earnings per share | 2.63 USD/share | 7.39 USD/share | 8.14 USD/share | 12.13 USD/share | 8.38 USD/share |
| Diluted earnings per share | 2.62 USD/share | 7.3 USD/share | 7.93 USD/share | 11.69 USD/share | 7.98 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.